Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol-lidocaine versus fentanyl-midazolam for cataract surgery
IRCT20181027041480N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cataract comparing Lidocaine + paracetamol with Fentanyl + midazolam (2 arms). Primary endpoints: Pain, Mean arterial pressure and 3 more. Started Jun 2019; status: completed.
02
Drugs
acetaminophenlidocainefentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20181027041480N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181027041480N1.